Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
CO
Chr. Olesen Pharma Latin A/S
aktivCVR 39463989AktieselskabJægersborg Alle 164, 2820 GentofteEngroshandel med medicinalvarer og sygeplejeartikler
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 15 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Data quality concern—
Data quality concern
Operating profit
DKK 192.7k
Latest period
Source details
Source: dk-regnskabsdata-live-39463989-1794760161740
Document: dk-regnskabsdata-39463989-AZ0CNwsqrcE9-QwkvtD_-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Oct 2024 - 30 Sept 2025
Technical details
Context: D0
Unit: U-iso4217-EUR
Net result
DKK 107.3k
Latest period
Source details
Source: dk-regnskabsdata-live-39463989-1794760161740
Document: dk-regnskabsdata-39463989-AZ0CNwsqrcE9-QwkvtD_-1
XBRL: fsa:ProfitLoss
Period: 01 Oct 2024 - 30 Sept 2025
Technical details
Context: D0
Unit: U-iso4217-EUR
Equity
DKK 722.5k
Equity ratio: 25%
Source details
Source: dk-regnskabsdata-live-39463989-1794760161740
Document: dk-regnskabsdata-39463989-AZ0CNwsqrcE9-QwkvtD_-1
XBRL: fsa:Equity
Period: 01 Oct 2024 - 30 Sept 2025
Technical details
Context: I0
Unit: U-iso4217-EUR
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | — | DKK 377.3k |
| 2023 | — | DKK 153.5k |
| 2024 | — | DKK 252.5k |
| 2025 | — | DKK 107.3k |